The influence of target population on nonculture-based detection of markers of Neisseria gonorrhoeae antimicrobial resistance
- 5 October 2012
- journal article
- research article
- Published by CSIRO Publishing in Sexual Health
- Vol. 9 (5) , 422-429
Abstract
Background: With treatment options for gonorrhoea (Neisseria gonorrhoeae) diminishing, strengthening antimicrobial resistance (AMR) surveillance is paramount. Methods: In this study, we investigated polymerase chain reaction (PCR) based methods, in parallel with N. gonorrhoeae multi-antigen sequence typing (NG-MAST), for direct detection of four N. gonorrhoeae chromosomal mechanisms associated with emerging resistance to extended spectrum cephalosporins using noncultured samples: an adenine deletion in the mtrR promoter, a mosaic penicillin-binding protein (PBP) 2, an A501V PBP2 mutation, and alterations at positions 120 and 121 of the porB protein. The PCR assays were validated using a panel of characterised N. gonorrhoeae isolates (n = 107) and commensal Neisseria (n = 100) species. These PCR assays with NG-MAST were then applied to noncultured clinical specimens from distinct populations in Australia with differing levels of N. gonorrhoeae AMR: the Northern Territory (NT), where resistance has a low population prevalence, and Queensland (Qld), with higher AMR prevalence. Results: The real-time PCR assays proved highly sensitive and specific. When applied to the noncultured samples, only 1 out of 50 (2%) samples from NT harboured a resistant mechanism, whereas the Qld samples (n = 129) collected over different periods showed progressive acquisition of resistant mechanisms, and these were associated with specific NG-MAST types, including Type 225. Conclusions: The results suggest that our PCR-based methods could be used to rapidly pinpoint incursion of resistant strains into previously unaffected populations. Likewise, our results show that for molecular AMR surveillance, the population being investigated is as important as the genetic mechanisms being targeted.Keywords
This publication has 29 references indexed in Scilit:
- High-Level Cefixime- and Ceftriaxone-Resistant Neisseria gonorrhoeae in France: NovelpenAMosaic Allele in a Successful International Clone Causes Treatment FailureAntimicrobial Agents and Chemotherapy, 2012
- Trends in Antimicrobial Resistance in Neisseria gonorrhoeae Isolated in Canada: 2000–2009Sexually Transmitted Diseases, 2011
- Sustainable Antimicrobial Surveillance Programs Essential for Controlling Neisseria gonorrhoeae SuperbugSexually Transmitted Diseases, 2011
- Is Neisseria gonorrhoeae Initiating a Future Era of Untreatable Gonorrhea?: Detailed Characterization of the First Strain with High-Level Resistance to CeftriaxoneAntimicrobial Agents and Chemotherapy, 2011
- Analysis of mutations in multiple loci of Neisseria gonorrhoeae isolates reveals effects of PIB, PBP2 and MtrR on reduced susceptibility to ceftriaxoneJournal of Antimicrobial Chemotherapy, 2011
- Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in SwedenSexually Transmitted Infections, 2010
- Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink?Journal of Antimicrobial Chemotherapy, 2010
- Neisseria gonorrhoeae and emerging resistance to extended spectrum cephalosporinsCurrent Opinion in Infectious Diseases, 2009
- Neisseria gonorrhoeae Isolates with Reduced Susceptibility to Cefixime and Ceftriaxone: Association with Genetic Polymorphisms in penA , mtrR , porB1b , and ponAAntimicrobial Agents and Chemotherapy, 2007
- Amino Acid Substitutions in Mosaic Penicillin-Binding Protein 2 Associated with Reduced Susceptibility to Cefixime in Clinical Isolates of Neisseria gonorrhoeaeAntimicrobial Agents and Chemotherapy, 2006